Adult ADHD is underdiagnosed, and that fact is not controversial among clinicians who see it regularly. The problem is that most people, and many physicians, still picture the restless eight-year-old who can’t stay in his seat. That image doesn’t capture the 40-year-old attorney who loses her keys every morning, misses deadlines despite genuine effort, and has spent two decades thinking she simply lacks discipline. ADHD in adults rarely looks like childhood ADHD, and because the diagnostic picture is different, many adults go unrecognized until the accumulated failures become hard to ignore.
A more accurate frame than “attention deficit” is executive function. ADHD disrupts the cognitive systems responsible for planning, prioritizing, initiating tasks, and managing time, not the raw ability to pay attention. People with ADHD can often concentrate intensely on things that interest them, which leads to the dismissive observation that their attention is “fine when they want it to be.” That misses the point. The difficulty is with deliberate, self-directed attention, particularly toward tasks that are effortful, dull, or have consequences that feel distant. Chronic disorganization, impulsivity, and emotional reactivity are common alongside the more familiar concentration problems, and together they create a pattern that is recognizable if someone is actually looking for it.
Stimulants remain first-line treatment despite the cultural skepticism that surrounds them, and the evidence supporting their use is among the strongest in outpatient psychiatry. One practical reality patients encounter: stimulants are Schedule II controlled substances, which means no automatic refills and a new prescription required each month, a logistical difference from most other medications. Non-stimulant options such as atomoxetine or guanfacine exist and are sometimes preferred when stimulants aren’t well tolerated or when a controlled substance isn’t appropriate, though they generally work more slowly and require more patience. Whatever medication is appropriate, ongoing medication management matters; dosing often needs adjustment as life circumstances change, and monitoring for side effects is part of the process.
An evaluation with Dr. Sharpe begins with a thorough clinical interview rather than a checklist or an online screener. Because ADHD by definition begins in childhood, the interview covers early history: how the person functioned in school, in relationships, in first jobs, not just current complaints. Academic records, occupational history, and when available, input from someone who knows the patient well, all contribute to a more complete picture. The goal is to determine whether ADHD explains the pattern, whether something else does, or whether multiple things are happening at once, and to build a treatment plan accordingly.
Frequently Asked Questions
Can ADHD really be diagnosed for the first time as an adult?
Yes. Many adults with ADHD spent childhood and adolescence developing workarounds that masked the condition: good enough grades, supportive environments, or sheer effort. When demands increase in college, in careers, or in parenting, those workarounds stop working. A first diagnosis at 30 or 45 is not unusual and does not mean the condition is new; it means it went unrecognized.
How is adult ADHD evaluated?
Dr. Sharpe conducts a thorough clinical interview covering current symptoms, early history, and how the person functioned in school and early jobs. Because ADHD begins in childhood by definition, that history matters. Academic records, occupational patterns, and input from someone who knows the patient well can all contribute. The goal is to determine whether ADHD explains the picture, or whether something else is going on.
Can ADHD be confused with anxiety or depression?
Frequently. Chronic disorganization, missed deadlines, and repeated underperformance often produce real anxiety and low mood, which can obscure the underlying ADHD. The reverse is also true: anxiety and depression can impair concentration in ways that resemble ADHD. Careful evaluation looks at the full history and sequence of symptoms rather than treating the presenting complaint in isolation.
What if I don’t want to take stimulants? Are there alternatives?
Non-stimulant medications, including atomoxetine and guanfacine, are established options. They are often preferred when stimulants are not well tolerated, when a controlled substance is not appropriate, or simply when a patient prefers them. Non-stimulants generally work more slowly and require more patience before the full effect is clear, but for many patients they are effective.
Why does my insurance treat ADHD medication differently?
Stimulants are Schedule II controlled substances under federal law. That classification means no automatic refills and a new written prescription required each month. Some insurers also impose prior authorization requirements or quantity limits that do not apply to other medication classes. These are regulatory and administrative constraints, not judgments about the legitimacy of the diagnosis or treatment.